The present invention relates generally to the generation of aerosol particles, and specifically to methods and systems for high throughput generation of aerosols with stable, monodispersed, submillimeter-sized micro-shell particles using gas jets and falling films.
Aerosols are useful in many industries, including medical, pharmaceutical, and food industries. In the medical field, aerosols can be useful for the delivery of therapeutic or diagnostic agents, as they avoid problems associated with other delivery methods such as oral administration (acidic environment of body/stomach, the ability of the agent to pass through the walls of the intestines, the liver's metabolizing of the agents, etc.) or injection (pain, risk of infection, hazardous waste generation, etc.). Aerosols can deliver an agent directly to a target area, such as the eye, or the nasal or respiratory tract. The latter can be an efficient way of direct delivering drugs to treat COVID-19 patients.
There are multiple types of aerosols, including, e.g., liquid droplets, as well as what are called bubble aerosols. Bubble aerosols consist of liquid particles having a thin liquid shell surrounding a gas core, which are suspended in a carrier gas flow or environment.
In order for droplet aerosols to be useful in biomedical applications, however, either the aerosols must be generated at the point of use, or they must have long-term stability. The two types of currently functional aerosols include aerosols of liquid droplets, generated by nebulizers and metered-dose inhalers, and aerosols of dry particles, which are separately produced and loaded into dry powder inhalers. Both nebulizers and metered-dose inhalers are point of use devices that create aerosols of liquid droplets by forcing a liquid suspension through an orifice to generates an aerosol. Neither has long-term stability—both generate aerosols that need to last seconds, at most. Additional disadvantages of those devices include generation of polydisperse droplet size distributions, low particle deposition in the lower airways of the human respiratory system, and the difference in the concentration of a therapeutic agent between delivered droplets compared to an initial solution, which all pose risks of insufficient or excessive medicine delivery. And neither of those two devices can generate aerosols of uniform-diameter particles, as well as liquid micro-shells (aerosol bubbles), which can be used as drug carriers and instantly solidified by either solvent evaporation, freezing or a chemical reaction. In addition, none of the current devices generating aerosols of droplets has additional functionality of formation of fine monodisperse liquid or solid foams simply by collecting liquid micro-shells from the generated aerosol on a surface or in a vessel, while the liquid walls of particles of adhere to each other and then can solidify due to solvent evaporation, freezing or polymerization.
Therefore, a system and method for generating stable aerosols of uniform-diameter liquid micro-shells are useful and desirable.
A first aspect of the present disclosure is a system for generating monodisperse bubble aerosols, consisting of uniform-diameter submillimeter-diameter particles having a thin liquid shell surrounding a gas core. The system includes a frame configured to create a falling film having a thickness less than 20 μm, where the falling film has a first end (a top), a second end (a bottom), and an intermediate portion. The system also includes a small nozzle configured to direct a gas towards the intermediate portion of the falling film, preferably in a direction perpendicular to a surface of the falling film, and a controller that is adapted to control the pressure of the gas provided to the nozzle, the pressure being between 10 and 1500 mbar.
The system may contain a pump configured to provide a liquid to the top portion of the falling film at a controlled rate, a camera directed at the intermediate portion, and/or a container to collect the liquid from the bottom of the falling film. The liquid used to form the falling film may optionally have a viscosity less than 100 mPa·s at 25° C., and may optionally contain an additional material that is suspended or dissolved in the liquid, such as an active pharmaceutical ingredient (API). The supplied gas directed into the nozzle may optionally contain suspended micron- or nano-sized particles or droplets, which may comprise an API. The nozzle may optionally have an inner diameter of less than 1 mm, or less than 1 μm. Optionally, the system may utilize a bank of nozzles blowing in parallel on one or more falling films. Optionally, a carrier gas is supplied to dilute or direct the flow of the generated bubble aerosol. The system preferably creates monodisperse aerosol bubbles, which are uniform-diameter particles having a thin liquid shell surrounding a gas core. Thus, aerosols of bubbles are essentially aerosols of liquid micro-shells, and those two terms are used interchangeably through this text. Optionally, the generated liquid shells may have an average outer diameter (or a maximum outer diameter) less than 1 mm. Optionally, the produced liquid shells may have a wall thickness of less than 5 μm. Optionally, the film is created by either pumping a liquid containing small amount of surfactant to the top of a vertically-oriented frame and allowing the liquid to create the film as it falls, or periodically dipping the frame into a liquid containing surfactant. Optionally, the system includes a second falling film, and optionally the aerosol bubbles that are formed from the first falling film then pass through the second falling film. This process optionally creates a multi-layer shell structure, around the central core, which initially comprises the gas.
A second aspect of the present disclosure is drawn to a method for generating bubble aerosols, which preferably relies on the system described previously. The method involves
creating a falling film from a liquid containing a dissolved surfactant, the falling film having a thickness of less than 20 μm; and then generating a plurality of liquid micro-shell particles by providing a gas at a pressure of between 10 and 1500 mbar to a nozzle configured to direct the gas through the falling film. The method may optionally include solidification of aerosol bubbles, by either solvent evaporation, freezing or chemical reaction like polymerization, collecting the plurality of aerosol bubbles, and/or generating a solid foam material from the plurality of aerosol bubbles. Optionally, the method involves generating between 1500 and 5000 uniform-diameter liquid micro-shells are generated per second per nozzle.
The present invention is drawn to a system and method for creating stable, monodisperse aerosol of micro-shell particles, the aerosols comprising particles having liquid shell of micron-scale thickness surrounding a gas core (sometimes referred to herein as “aerosol bubbles”).
As used herein, “monodisperse” refers to particles having substantially uniform outer dimensions. In some embodiments, the polydispersity index (PI), a measure of the heterogeneity of a sample based on size, is used to reflect the dispersity of the particles. Assuming a gaussian distribution of particle sizes, the PI is generally understood as the square of (standard deviation/mean diameter of the particles). The PI can be obtained from instruments that use dynamic light scattering (DLS) or determined from electron micrographs. International standards organizations (ISOs) have established that PI values <0.05 (5%) indicate a highly monodisperse sample, while values >0.7 (70%) indicate a broad distribution (e.g., polydisperse) of particle sizes (ISO standards ISO 22,412:2017 and ISO 22,412:2017). PI values <0.1 (10%) are generally understood as being monodisperse. As such, in preferred embodiments, the monodisperse particles have PI values <0.05, <0.04, <0.03, <0.02, or <0.01.
The system can best be understood referring to
Nozzle
The nozzle 40 is shown in
Referring to
Referring to
The nozzles utilized in the disclosed systems preferably have a circular cross-section, and the end of each nozzle is preferably a flat surface perpendicular to the direction the gas is flowing through the nozzle. Preferably the nozzles do not contain a bevel, such as those seen on regular hypodermic needles.
The nozzles may be of almost any material. For example, in some embodiments, the walls defining a nozzle are comprised of a metal (such as stainless steel, platinum, etc.) or a glass (such as a silicon dioxide glass).
In some embodiments, the nozzles 40 may be attached to a frame 34, positioned on one side of the falling film 30. In other embodiments, the nozzle is not attached to the frame 34. In some embodiments, the nozzles are in a fixed position and fixed orientation, while in others, the nozzles may vary in position, orientation, or both. For example, in some embodiments, a nozzle can be connected to spatial positioners driven by motors which control the location of a given nozzle's 2-D location (in a plane parallel to the film), and/or spatial positioners driven by motors which control the orientation of a given nozzle with respect to the film. In preferred embodiments, each nozzle 40, 44 is oriented such that the stream 41, 45 is oriented 90° (normal/perpendicular) to a first surface 36 of the falling film 30. In other embodiments, one or more streams 41, 45 deviates from normal to the first surface 36 by ≤5°, ≤10°, ≤15°, ≤20°, ≤25°, ≤30°, ≤35°, ≤40°, or ≤45° in any direction. Said differently, while the nozzles preferably direct a gas perpendicular to the surface of the film, it may sometimes be advantageous for the nozzles to direct the gas at a slight or moderate angle relative to the surface of the film.
Gas
The nozzle 40 is preferably connected to a flow control unit 50, such as a microfluidic flow control unit, that controls the flow of a gas from a source 51 to the nozzle 40. Flow control units are well known in the art and are commercially available in a variety of configurations. The flow control unit 50 is preferably adapted to control the pressure of the gas provided to each nozzle 40.
Skilled artisans will recognize that, to form aerosol bubbles, the pressure of the gas being provided to nozzle 40 is at least partially dependent on the characteristics of the falling film and the liquid used to form the falling film 30. For example, a thin film will require less pressure than a thicker film, and a liquid's viscosity and surface tension will also impact how much pressure is required. In some embodiments, the pressure existing the flow control unit 50 is ≥10 mbar, ≥20 mbar, ≥30 mbar, ≥40 mbar, ≥50 mbar, or ≥100 mbar, and is ≤1500 mbar, ≤1250 mbar, ≤1000 mbar, ≤800 mbar, or ≤600 mbar, and all combinations thereof. In some embodiments, the pressure p is 10 mbar≤p≤1500 mbar, while in other embodiments, 50 mbar≤p≤1000 mbar, and in still other embodiments, 100≤p≤800 mbar.
Referring briefly to
The gas that is used to create the aerosol bubble can include any gas or gas mixture and may also include a liquid or solid micro/nano-size particles suspended in the supplied gas or gas mixture. Typically, the gas or gas mixture will comprise a carrier gas that does not substantially react with other components in the system. This gas or gas mixture may comprise, e.g., air, CO2, N2, or O2, or noble gases like He, Ar, and the gas or gas mixture may or may not have been passed through filters prior to being used by the system.
In some embodiments, if the gas contains suspended micron- or nano-sized particles or droplets, the suspended particles or droplets comprise an active pharmaceutical ingredient (API), or biopharmaceutical materials, such as proteins or engineered microorganisms, etc. Other suspended materials or droplets may comprise a catalyst, food, or cosmetic ingredient, etc. For example, droplets can be used to encapsulate an active sunscreen ingredient, such as octocrylene, avobenzone, etc., and that encapsulated material can then be used in a sunscreen formulation.
In some embodiments, the suspended micron- or nano-sized particles or droplets are introduced to the gas or gas mixture prior to the flow control unit 50. In some embodiments, the suspended particles or droplets are introduced into the gas stream after the flow control unit 50. In some cases, this particles or droplets are metered into the gas through a Y-type connection.
In some embodiments, a carrier gas is supplied to dilute or direct the flow of the generated aerosol of micro-shell particles. Such carrier gas can be supplied either as a bulk environmental flow to which all the system shown in
In some embodiments, the gas may comprise non-pharmaceutical and non-medicinal agents, such as scent agents. In some embodiments, the gas comprises such scent agents in order to be used to encapsulate a desirable or masking scent (such as a fragrance). That is, in some embodiments, the process results in a plurality of aerosol bubbles encapsulating a fragrance, where the fragrance would generally not be released until the outer shell was dissolved, popped, etc. In some embodiments, the desirable scent is not an aesthetically pleasing scent; that is, in some embodiments, the scent agent is a malodorant.
Falling Film
The falling film 30 is typically formed on a frame 34, that uses, e.g., wires, to hold and provide an area for the film to form. A liquid 21 (including, e.g., as a pure liquid, a solution, an emulsion, or a liquid containing suspended particles) passes to a pump 20, which controls the rate of the liquid 21 flowing to the falling film 30. The falling film 30 generally has a top portion 31, a bottom portion 32, and an intermediate portion 33. The liquid 21 is pumped to the top portion 31. Gravity causes the film to fall from the top portion 31 towards the bottom portion 32, typically conforming to a shape defined by wires connected to the frame 34. In some embodiments, a tensioning weight 35 is attached to the wires near the bottom portion 32, to aid in maintaining a uniform falling film. The liquid 21, after passing through the falling film 30 from the top portion 31 to the bottom portion 32, then typically drains into a collection device 38, which is typically an appropriately-sized container (e.g., a beaker, a drum, etc.) or funnel. In some cases, the liquid 21 from the collection device 38 is recycled, pumped back to the top portion 31 of the falling film 30. In some cases, the recycling is done in-line, and the collected liquid is then pumped back to the top portion 31 of the falling film 30.
The falling film as shown in
In some embodiments, the film is initially generated using a relatively slow flow rate, and after the entire film is generated, the flow rate is increased until the desired film thickness is achieved.
Generally, the flow rate of the liquid can be used to control the thickness of the falling film. As seen in, e.g.,
While the minimum and maximum film thickness of a falling liquid that still allows for aerosol bubble formation will depend on the liquid's composition, films that can form aerosol bubbles will typically have a thickness of less than about 20 μm. In some embodiments, the thickness of the film is ≤20 μm, ≤18 μm, ≤16 μm, ≤14 μm, ≤12 μm, or ≤10 μm, and is ≥1 μm, ≥3 μm, ≥5 μm, or ≥10 μm, and all combinations thereof.
The wall thickness of the aerosol bubbles that are formed is at least partially based on the thickness of the falling film. As the film thickness increases, the wall thickness will also generally increase.
Additionally, as will be understood by those of skill in the art, the wall thickness is bound by the diameter of the aerosol bubble. It is physically impossible for a bubble with a 1 μm outer diameter to have 1 μm thick walls, for example. In some embodiments, the thickness of the walls is less than 20%, less than 10%, or less than 5% of the outer diameter of the bubble.
The composition of the liquid can vary, depending on the desired purpose of the aerosol bubble coating to be formed. The liquid will be a liquid. In some embodiments, the liquid comprises water and other water-soluble ingredients, such as alcohols (e.g., ethanol, etc.) or polyols (e.g., glycerol, etc.). In some embodiments, the liquid is non-aqueous. In some embodiments, the liquid is a solution. In some embodiments, the liquid is an emulsion. In some embodiments, the liquid contains an additional material that is suspended or dissolved in the liquid, such as an active pharmaceutical ingredient (API) or catalyst or monomer or oxidant. In some embodiments, the liquid also comprises a surfactant. The surfactants may be, e.g., pharmaceutically acceptable surfactants, including, e.g., non-ionic surfactants. In some embodiments, the surfactant has an HLB (hydrophilic lipophilic balance) value of from about 4 to about 10, preferably from about 7 to about 9. Surfactants having an HLB value of from about 4 to about 10 suitable for use in the present invention include for example, but are not limited thereto: polyoxyethylene alkyl ethers, e.g. polyoxyethylene (3) lauryl ether, polyoxyethylene (5) cetyl ether, polyoxyethylene (2) stearyl ether, polyoxyethylene (5) stearyl ether; polyoxyethylene alkylaryl ethers, e.g. polyoxyethylene (2) nonylphenyl ether, polyoxyethylene (3) nonylphenyl ether, polyoxyethylene (4) nonylphenyl ether, polyoxyethylene (3) octylphenyl ether; polyethylene glycol fatty acid esters, e.g. PEG-200 monolaurate, PEG-200 dilaurate, PEG-300 dilaurate, PEG-400 dilaurate, PEG-300 distearate, PEG-300 dioleate; alkylene glycol fatty acid mono esters, e.g. propylene glycol monolaurate (Lauroglycol®); sucrose fatty acid esters, e.g. sucrose monostearate, sucrose distearate, sucrose monolaurate, sucrose dilaurate; or sorbitan fatty acid mono esters such as sorbitan mono laurate (Span® 20), sorbitan monooleate, sorbitan monopalmitate (Span® 40), or sorbitan stearate, or mixtures of one or more thereof.
In some embodiments, the liquid includes other components, such as solvents, solubilizing agents, waxes, colorants, plasticizers, hydrophobic polymers, or hydrophilic polymers. A simple example is a liquid comprising water, 0.1-10% of a surfactant, and 0.1-5% of a hydrophilic polymer (such as polyethylenimine (PEI)).
The nozzles in the system are preferably directed towards the intermediate portion 33 of the falling film 30, avoiding any thickness or velocity gradients near the edges that might negatively impact uniformity. The length and width dimensions of the intermediate portion 33 can vary significantly. In some cases, the length of intermediate portion 33 is ≤200 cm, ≤150 cm, ≤100 cm, ≤50 cm, ≤25 cm, ≤10 cm, or ≤5 cm. In some cases, the width of intermediate portion 33 is less than ≤20 cm, ≤10 cm, ≤8 cm, or ≤5 cm, or ≤1 cm, or ≤0.5 cm In some embodiments, the overall length of the falling film 30 is ≤250 cm, ≤200 cm, ≤150 cm, ≤100 cm, ≤50 cm, ≤25 cm, or ≤10 cm, or ≤5 cm, or ≤1 cm.
In some embodiments, the nozzles are directed towards the center of the intermediate portion 33 of the falling film 30, ±25% of the width and/or length. That is, if the film is 8 cm wide and 20 cm long, the nozzles are generally directed at a portion of the film that is 4 cm from the left side of the intermediate portion 33, ±2 cm, and 10 cm from the top of the intermediate portion 33, ±5 cm. In some embodiments, all nozzles are within this centralized target range. In some embodiments, only some of the nozzles are within this centralized target range.
The system in
In preferred embodiments, the liquid of each falling film will have a viscosity ≤500 mPa·s, ≤250 mPa·s, ≤200 mPa·s, ≤150 mPa·s, or ≤100 mPa·s, at 25° C.
In preferred embodiments, the liquid of each falling film will have a surface tension ≤100 mN/m, ≤75 mN/m, ≤50 mN/m, ≤40 mN/m, or ≤30 mN/m.
Because each falling film 30, 31 may have different compositions, this allows a skilled artisan to create a layered aerosol bubble structure, or a core-shell particle. Referring briefly to
The use of multiple films also allows the creation of unique particle configurations. In some embodiments, one layer forms a hydrophobic shell, while another layer forms a hydrophilic shell, which can remain “wet” or can be dried. In some embodiments, a first layer uses a polymer material that can be quickly solidified (e.g., by drying, photopolymerization, etc.) to form a solid shell, and then the second falling film the second layer can remain “wet” or can be dried as well. This process can be repeated as long as the aerosol bubble/shell still have enough inertia to pass through a film. So the aerosol bubbles that are created can be a hollow dry multi-layer particle, and inside the central void of such particle there could be a gas and liquid/dry nanoparticles of a useful material, like medical drug, catalyst, food, or cosmetic ingredient, etc.
In preferred embodiments, all aerosol bubbles (shells with thin liquid walls and gas core) that are generated are monodisperse with respect to all other aerosol bubbles generated by all nozzles. In some embodiments, all aerosol bubbles that are generated from each nozzle is monodisperse with respect to the aerosol bubbles generated from that nozzle.
In some embodiments, the diameter (D) of the aerosol bubbles scales with the inner diameter (ID) of the nozzle, such as D=x ID, where generally 1<x<10. In some embodiments, 2<x<4. For example, with an approximately 110 μm inner diameter nozzle, aerosol bubbles were created that had bubble diameters of around 300 μm. In other examples using the same nozzle, the bubble diameters could be varied from between 300 and 800 μm, depending on various flow and liquid conditions.
In some embodiments, the generated aerosol bubbles have an average diameter (Davg)<1 mm, <750 μm, <500 μm, <250 μm, or <100 μm. In some embodiments, the generated aerosol bubbles have a maximum diameter (Dmax)<1 mm, <750 μm, <500 μm, <250 μm, or <100 μm, or <50 μm, or <20 μm, or <10 μm, or <5 μm, or <1 μm.
In preferred embodiments, the thickness of each shell or wall of the produced aerosol bubbles is ≤5 μm, ≤4 μm, or ≤3 μm, or ≤2.5 μm, and ≥0.5 μm, ≥1 μm, ≥1.25 μm, or ≥1.5 μm, and any combination thereof. In preferred embodiments, the average thickness of each shell or wall of the produced aerosol bubbles is 0.5 μm±0.12 μm, 1 μm±0.25 μm, 2 μm±0.25 μm, 3 μm±0.25 μm. These thin walls can enable rapid evaporation of solvents in the bubble walls.
Because of the small diameters and relatively thin walls, each aerosol bubble particle is very light, generally weighing ≤20 μg, ≤15 μg, ≤10 μg, or ≤5 μg, or ≤1 μg. This can enable precise delivery of materials, as very small payloads can be directed to a target location.
The throughput of the produced aerosol bubbles can vary dramatically. For example, in some experiments, the particle throughput was 1500-3500 aerosol bubbles per second, which translates to 10-30 mg/s. In some embodiments, the particle throughput was 1500-5000 aerosol bubbles per second per nozzle.
Given that thousands of aerosol bubbles can be generated quickly, these streams of bubbles can be collected (e.g., in a container, on a surface, etc.) and/or manipulated as desired.
In some instances, the aerosol bubbles are further dried and/or solidified, which may occur while the aerosol bubbles are in flight. In one example, a gas blowing on the film contains suspended micron/nano particles in it; these particles are then encapsulated by the aerosol bubble walls, which can solidify or not (depending on the solvent system, etc.) during their flight.
Alternatively, in some examples, polymers in a shell of the particles are cross-linked by exposed the aerosol bubbles to ultraviolet (UV) light. In some examples, the collected aerosol bubbles adhere to each other, and polymerize on the surface of the container or substrate that they were collected on. In some embodiments, the carrier gas can be saturated vapor of nitrogen or saturated vapor of carbon dioxide, which is supplied to solidify the generated liquid micro-shells by freezing them. In some embodiments, the carrier gas can be a monomer vapor, which is combined with a catalyst or an oxidant included in the micro-shells to promote chemical reaction of gas phase polymerization. In some embodiments, the carrier gas can be a catalyst gas, which is combined with a monomer included in the micro-shells to promote chemical reaction of polymerization.
In some embodiments, the process of collecting the aerosol bubbles results in a foam being generated on a surface or in a container (the bubbles will generally adhere to each other to create a foam with monodispersed gas bubbles), and the foam can remain liquid or solidify depending on the solvent in a falling film, and/or the drying and/or solidification process.
Bubbles in aerosol can also be used as transport agents for material delivery. That is, in some embodiments, the aerosol bubbles are configured to pop or dissolve when exposed to certain environments, which then release any materials contained within.
Additionally, while in preferred embodiments, the film is created by pumping the fluid (such as a liquid comprising a surfactant) to the top of a vertically-oriented frame and allowing the liquid to create the film as it falls, alternative approaches can be used. For example, in some cases, the film is created by periodically dipping frame into a liquid with a surfactant.
Other Components
Referring back to
The camera 60, if used, will preferably be directed to capture side/cross-sectional images of the intermediate portion 33 of the falling film 30, which during operations can result in images similar to the depiction shown in
In some embodiments, the light source 65 can be used to illuminate the falling film and/or aerosol bubbles, allowing the camera to capture better pictures of the film and/or aerosol bubbles.
In some embodiments, the light source 65 can be producing electromagnetic waves of an ultraviolet spectrum and a photopolymer is supplied with the solution 21 to form the thin film 30, so that when the ultraviolet light 65 is directed onto the generated liquid micro-shells, the light initiates and propagates a photopolymerization reaction for a photopolymer contained in the walls of the generated micro-shells.
In some embodiments, the processor 80 processes images captured by the camera 60 and makes determinations as to the thickness 37 of the falling film 30, and causes the pump 20 to adjust the rate the liquid is pumped to the falling film 30 to adjust the thickness of the film to reach a desired target or target range.
In some embodiments, the processor 80 processes images captured by the camera 60, by identifying aerosol bubbles 70, 71, 72, 73 and making at least one determination as to the throughput of the aerosol bubbles. The processor 70 then can cause the flow control unit 50 to adjust the flow rates of the gas one or more of the nozzles 40, 44, in order to adjust the throughput of the aerosol bubbles to a desired target or target range. If no aerosol bubbles are detected, this may include identifying if the nozzle is operating in the first regime 110 or the third regime 130, and adjusting the flow rate up or down, respectively, until aerosol bubbles appear.
In an experimental setup, soap solutions were used made by mixing a dishwashing liquid (surfactant), water and glycerol, that allowed production of falling soap films with thickness 2-15 μm, length 1.3 m and width 8 cm capable of living for tens of minutes. Standard blunt hypodermic needles with internal diameters 90-1000 μm were used as nozzles to provide an air jet from supplied air pressurized within the range 10-1000 mbar. The air jet out of the nozzle was blown perpendicularly to the film. Gradually increasing the air pressure before the nozzle, the three main regimes of gas jet-film interaction were observed, as shown in
Thus, a preferred method for generating aerosols of particles having liquid shell of micron-scale thickness surrounding a gas core (i.e., aerosol bubbles). The process generally involves providing a system as described above, creating a falling film from a liquid containing a dissolved surfactant, the falling film having a thickness of less than 20 μm, then generating a plurality of aerosol bubbles by providing a gas at a pressure of between 10 mbar and 1500 mbar to a nozzle configured to direct the gas through the falling film. A skilled artisan will recognize that some adjustment for the gas flow rate and/or thickness of the film may need to be taken into account in order to stay within the second regime 120 and form a stream of monodisperse aerosol bubbles. In some embodiments, the liquid for the falling film contains the dissolved surfactant and at least one additional material that is suspended or dissolved in the liquid, as described above.
The method may also involve, for example, drying and/or solidifying the aerosol bubbles, generating a solid foam material from the plurality of aerosol bubbles, and collecting the plurality of aerosol bubbles, such as in a container or on a surface.
Referring to
The first option involves the direct delivery of the medicine. That is, the aerosol bubbles are transported to a patient, who then can have the medicine administered (via, e.g., inhalation). In one embodiment, the aerosol bubbles are directed through tubes to, e.g., a mask, which allows the medicine to be inhaled directly.
The second option is to form a dry powder of micro-shells. This option will generally involve evaporation of the solvent and/or solidification of the liquid micro-shell in the aerosol via known techniques.
The third option is to create a soft or solid foam, which involves the collection of the liquid micro-shells and optionally directing the collected liquid micro-shells to form a particular shape, and then solidifying them.
The fourth option is to generate a liquid foam material, which involves collecting the liquid micro-shells, and optionally directing the collected liquid micro-shells to form a particular shape.
In some embodiments, the falling film is created by pumping a liquid, at a controlled rate, to the top portion of the falling film. In some embodiments, images of the aerosol bubbles being produced are captured by a camera. In some embodiments, a container or funnel is used to capture liquid leaving the bottom of the falling film. In some embodiments, the liquid forming the falling film has a viscosity less than 100 mPa·s at 25° C. In some embodiments, the liquid forming the falling film contains an additional material that is suspended or dissolved in the liquid, such as an active pharmaceutical ingredient (API). In some embodiments, the gas being provided contains suspended micron- or nano-sized particles or droplets, such as an API. In some embodiments, the nozzle has an inner diameter <1 mm, or <1 μm. In some embodiments, a bank of nozzles is used to blow the gas, in parallel, on the falling film. In some embodiments, a carrier gas is supplied to dilute or direct the flow of the generated bubble aerosol. In some embodiments, the aerosol bubbles are monodisperse bubbles, and/or have an average diameter less than 1 mm and/or a maximum diameter less than 1 mm, and/or a wall thickness of less than 5 μm. In some embodiments, the film is created by either pumping liquid comprising a surfactant to the top of a vertically-oriented frame and allowing the liquid to create the film as it falls, or periodically dipping frame into liquid with surfactant.
The disclosed systems and methods can be used, inter alia, as a process technology for producing a product. The disclosed approach may be employed in the production of aerosols with bubble particles carrying a medicine which can be directed into human airways. Another possibility is the collection of generated aerosol bubbles on a plate or in a vessel to make a foam which can be further used for healthcare applications (e.g., medical diagnostics). Additionally, the disclosed approach may be employed for the drying/solidification of generated aerosol bubble particles and would make possible manufacturing in this way of solid spherical shells for pharmaceutical/material/cosmetics/food applications. Additionally, the disclosed approach may be employed for the drying/solidifying of a foam produced from the collected aerosol bubble particles to manufacture in this way solid foam materials.
Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.
This application claims priority to U.S. Provisional Patent Application No. 62/939,179, filed Nov. 22, 2019, which is hereby incorporated in its entirety by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2020/061186 | 11/19/2020 | WO |
Number | Date | Country | |
---|---|---|---|
62939179 | Nov 2019 | US |